Skip to main content

Table 2 Aids-Defining illnesses diagnosed concomitantly with TB, n = 310, INI-Fiocruz cohort, 2000–2010

From: Mortality in patients with HIV-1 and tuberculosis co-infection in Rio de Janeiro, Brazil - associated factors and causes of death

Pneumocystis jirovecii pneumonia; n (%)

42 (13.5)

Candidiasis, Esophageal (presumptive diagnosis); n (%)

18 (5.8)

Toxoplasma gondii encephalitis; n (%)

16 (5.2)

Cytomegalovirus disease (colitis, esophagitis, disseminated); n (%)

6 (1.9)

Histoplasmosis, disseminated; n (%)

5 (1.6)

Kaposi’s sarcoma; n (%)

5 (1.6)

Cryptosporidiosis; n (%)

3 (1.0)

Cryptococcal meningoencephalitis; n (%)

3 (1.0)

HIV-1 encephalopathy; n (%)

1 (0.3)

Lymphoma; n (%)

1 (0.3)

  1. Aids-defining illnesses were defined according to the CDC 1993 definition [15]. A concomitant Aids defining illness was considered when it occurred within 30 days before or after TB treatment initiation